| Size & multiples | |||
| Market Cap | — | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | — | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | — | Buyback Yield | — |
| Owner Earnings (TTM) | SEK 214.9M | Owner Earnings Yield | — |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | — | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | — |
| After-tax Cost of Debt | 5.33% | WACC | — |
| ROIC | 36.67% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF sits 80% below owner earnings — spending above maintenance (growth capex) or absorbing working capital, so FCF understates the steady-state cash the business throws off.
Flows latest annual · EPS TTM SEK 2.09 · revenue TTM SEK 6.56B · FCF TTM SEK 43.4M (in SEK)
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E, EV/EBITDA
P/E 71st · EV/EBITDA 67th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 35.6x | 24.4x | 13.0x–39.3x | 71 ↑rich |
| EV/EBITDA | 19.5x | 15.1x | 9.8x–24.4x | 67 ↑rich |
| FCF Yield | 0.6% | -7.8% | -34.7%–1.4% | 71 ↑strong |
| Net Margin | 3.3% | -21.2% | -325.3%–7.2% | 69 ↑strong |
| Operating Margin | 4.1% | -34.5% | -552.0%–8.0% | 70 ↑strong |
| ROE | 42.2% | -36.8% | -92.5%–4.5% | 97 ↑strong |
